Keyphrases
Hepatocellular Carcinoma
100%
High Cost
100%
Cost-effectiveness
50%
Treatment Options
50%
Sorafenib
50%
Clinical Trials
25%
Potential Impact
25%
Cancer Causes
25%
Cancer Mortality
25%
Systemic Therapy
25%
Patient Outcomes
25%
Randomized Clinical Trial
25%
Advanced Disease
25%
Patient Selection
25%
Chronic Liver Disease
25%
UK National Health Service
25%
Standard of Care
25%
Systemic Treatment
25%
National Guidance
25%
Novel Agents
25%
Novel Combinations
25%
Funding Decisions
25%
Advanced Hepatocellular Carcinoma
25%
Single Technology Appraisal
25%
Multikinase Inhibitor
25%
Local Public Finance
25%
Treatment Indication
25%
Medicine and Dentistry
Health Care Cost
100%
Hepatocellular Carcinoma
100%
Systemic Therapy
40%
Cost-Effectiveness Analysis
40%
Sorafenib
40%
Decision Making
20%
Clinical Trial
20%
Cancer Mortality
20%
Randomized Clinical Trial
20%
National Health Service
20%
Chronic Liver Disease
20%
Diseases
20%
Nursing and Health Professions
Liver Cell Carcinoma
100%
Cost Effectiveness Analysis
40%
Sorafenib
40%
Systemic Therapy
40%
Socialized Medicine
20%
Treatment Outcome
20%
Health Care Quality
20%
Cancer Mortality
20%
Chronic Liver Disease
20%
Diseases
20%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Sorafenib
40%
Clinical Trial
20%
Cancer Mortality
20%
Randomized Clinical Trial
20%
Chronic Liver Disease
20%
Systemic Treatment
20%
Diseases
20%